The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.EBI
Guangzhou University of Chinese Medicine
Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases.EBI
Guangzhou University of Chinese Medicine
The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance.EBI
Guangzhou University of Chinese Medicine
Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.EBI
Guangzhou University of Chinese Medicine
Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[EBI
Guangzhou University of Chinese Medicine
Meroterpenoids produced by fungi: Occurrence, structural diversity, biological activities, and their molecular targets.EBI
Guangzhou University of Chinese Medicine
Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia.EBI
Guangzhou University of Chinese Medicine
Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.EBI
Guangzhou University of Chinese Medicine